A CFO Departure. A Clinical Miss.
Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now
Here's How Many Shares of Pfizer You Must Own to Get $5,000 in Yearly Dividends
Pfizer: Why Being Bullish Makes Sense Despite The Patent Cliff
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026?
MRK Gets EU Nod for Keytruda & Padcev Combination in Bladder Cancer
Pfizer (PFE) Falls More Steeply Than Broader Market: What Investors Need to Know
Pfizer Declares Third-Quarter 2026 Dividend
FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance
FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance
Nike names former Pfizer CFO David Denton as finance chief
Pfizer dismissed from US states' drug price-fixing lawsuit
LLY or PFE: Which Drugmaker Offers the Stronger Growth Story?
Pfizer Stock Trades Flat Following Mixed Phase 3 Lung Cancer Trial Data
Nike's New CFO Isn't a Retail Insider—He's Coming From Pfizer
Biotech's Silent Resurgence (5-Year Base Breakout)
2 High-Yield Dividend Stocks to Buy and Hold for a Decade
Nike Names Pfizer's Denton as Next CFO
Forget Novo Nordisk. Pfizer's Obesity Pipeline Is Coming, and It Pays You 6.8% While You Wait
Javelin Biotech and Pfizer Announce Landmark Publication Demonstrating Clinical PK Predictions Using Multi-Tissue Chip Platform
Major Indexes Continue Lower as Chip Selloff Drags Nasdaq
China outpacing Europe in drug innovation and development, Pfizer executive says
Pfizer's Mixed Phase III Data for Sigvotatug Vedotin in NSCLC
Pfizer's experimental drug misses main goal of lung cancer trial
Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer
Eli Lilly vs Pfizer: One Owns the Obesity Market Today, The Other Paid to Compete Tomorrow
Pfizer Stock Edges Lower Monday: What's Going On?
Pfizer Isn't Expecting to Make Any Big Acquisition in the Next Couple of Years, but It's Planning to Do This Instead
Could Pfizer Stock Be Your Ticket to Generational Wealth?
Own 500 Shares of Pfizer and JNJ and Here's Your Annual Dividend Income
Pfizer's Dividend Yield is 10X Bigger Than Eli Lilly's. Does That Make It the Better Stock for Income Investors?
PFE Stock Slides Following CFO Exit, 2026 Guidance Reaffirmed
Stock Market Today, June 18: Pfizer Falls as CFO Transition Tests Confidence in 2026 Outlook
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors
Pfizer Stock Drops Today As CFO Steps Down In August
Can Pfizer Take Share From Lilly & Novo Nordisk in the Obesity Space?
Pfizer CFO Dave Denton to step down, leave company in August
Pfizer Announces Chief Financial Officer Transition
Pfizer: Why I'm Still Expecting A Massive Rebound
Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?
Here's When Pfizer's CEO Says the Company Might Get Back to Generating High-Single-Digit Growth
Is Pfizer's Discounted Valuation a Buying Opportunity or a Value Trap?
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
3 Stocks With a Yield Over 6% For Passive Income Investors
Pfizer's New Weight-Loss Data Just Gave Eli Lilly and Novo Nordisk Investors Something to Worry About
Forget Eli Lilly and Company: As June Volatility Rocks High-Flyers, This Stock Is a No-Brainer Buy
Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know
This $25 Billion Acquisition Just Unlocked a New Era of Growth for Pfizer — and Why It's a Flawless Safe-Haven for Retirees
A Sizzling 6.7% Dividend Yield? 1 Under-the-Radar Reason I Am Holding Off on Pfizer Stock at $25